News Focus
News Focus
icon url

Nerf

03/11/08 3:36 PM

#3745 RE: docbanker #3744

y3max wants to know about Japanese pharma!!!!!!
icon url

ethan77

03/11/08 5:08 PM

#3751 RE: docbanker #3744

Thanks Doc
icon url

Bio_pete

03/11/08 5:51 PM

#3752 RE: docbanker #3744

Thanks for the update. Thats the best way to respond to the FUD.

Hit em straight..

Bio_pete
icon url

corpstrat

03/11/08 6:59 PM

#3753 RE: docbanker #3744

Thanks from me, too. Sounds good to the layperson. Wonder if Dewophile, Clark or io have comments on any of those responses.

Nice to have confirmation that there will be more efficacy data out in next 30 days and that the 4 P III trials are getting under way in this timeframe. Looks like a possible month's slippage on those (?), but that's to be expected.

Repros's is an amazingly productive team. Astonishingly under-appreciated.
icon url

exwannabe

03/11/08 7:22 PM

#3755 RE: docbanker #3744

Sounds just like Tony Snow interviewing Bush.

How about some real questions?

Why 15 patients in the palceboe arms of the 4 trials, especially when you know many will drop out?

Why no SPA?

The FDA does not like companies to use higher dosages than have been shown effective. For anemmia, why is the 15mg dose not in the P3?

What are the endpoints? In particular the company states the trials are 2.5X bigger than the P2s. So, this implies a composite endpoint of both arms treatment arms, or a P reduction. If composite, isn't that a danger in the fibr. trial? If a P reduction, what?


I know all these issues were beaten to death, so no need to ask. Just present the softballs.

icon url

io_io

03/11/08 9:37 PM

#3760 RE: docbanker #3744

Thanks for sharing Doc.....EOM